Pneumococcal vaccination coverage in elderly people in Belgium

Archives of Public Health

Volumn 63, Issue 4, 2005, Pages 185-197

  Bossuyt, Nathalie ^a   Van Casteren, V ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

23 valent pneumococcal capsular polysaccharide vaccine; Belgium; Family physicians; Streptococcus pneumoniae; Vaccination

Indexed keywords

EID: 34447270778     PISSN: 07787367     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fedson DS, Scott JA Scott G. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 1999; 17 Suppl 1:S11-8.
2. Felkin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L. et al. Mortality from invasive pneumococcall pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000; 90(2):223-9.
3. Peleman RA, Peetermans WE, Van Laethem Y, Bachez PG, Vanatoru J, Van Wassenhove K, et al. Prevention of pneumococcal disease: an update on the Belgian Consensus Report, Acta Clin Belg 1999; 54(6):321-7.
4. Peetermans W. Pneumokokkenvaccinatie in België in 1996 en 1997. Tijdschr Geneeskd 1998; 54(17):1196-200.
5. Flamaing J, Verhaegen J, Peetermans WE. Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population and implications for vaccine use. J Antimicrob Chemother 2002; 50(1):43-50.
6. Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994; 154(23):2666-77.
7. Konradsen HB. Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons. Clin Infect Dis 1995; 21(3):616-20.
8. Sankilampi U, Honkanen PO, Bloigu A, Leinonen M. Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly. J Infect Dis 1997; 176(4):1100-4.
9. Mufson MA. Antibody response of pneumococcal vaccine: need for booster dosing? Int J Antimicrob Agents 2000; 14(2):107-12.
10. Working Party on Pneumococcal Vaccine. Belgian consensus on pneumococcal vaccine. Acta Clin Belg 1996; 51(5):350-6.
11. WVVH. De Wetenschappelijke Vereniging van Vlaamse Huisartsen distantieert zich van de adviezen van de Hoge Gezondheidsraad in verband met de vaccinatie tegen pneumokokken [press release]. 17/01/1997.
12. WVVH. Wetenschappelijke Vereniging van Vlaamse Huisartsen verduidelijkt stand-punt in verband met vaccinatie tegen pneumococcen. 1997.
13. Van Houdt L. Over het Wei en wee van pneumococcenvaccinatie. Scoop 2000; December:4-5.
14. Kahn HA, Sempos CT. Statistical methods in epidemiology. New York: Oxford University Press, 1989.
15. Peetermans WE, Lacante P. Pneumococcal vaccination by general practitioners: an evaluation of current practice. Vaccine 2000; 18(7-8):612-7.
16. Squires SG, Macey JF, Tam T. Progress towards Canadian target coverage rates for influenza and pneumococcal immunizations. Can Commun Dis Rep 2001; 27(10): 90-1.
17. CDC. Influenza and pneumococcal vaccination levels among persons aged > or = 65 years - United States, 1999. MMWR Morb Mortal Wkly Rep 2001; 50(25):532-7.
18. Andrews RM. Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia. Vaccine 2005; 23(21):2756-61.
19. Kyaw MH, Wayne B, Chalmers J, Jones IG, Campbell H. Influenza and pneumococcal vaccine distribution and use in primary care and hospital settings in Scotland: coverage, practice and policies. Epidemiol Infect 2002; 128(3):445-55.
20. Fedson DS. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996. Clin Infect Dis 1998; 26(5):1117-23.
21. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults. A report on recommendations from the Task Force on Community Preventive Services. MMWR Recomm Rep 1999; 48(RR-8):1-15.
22. Willis BC, Ndiaye SM, Hopkins DP, Shefer A. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 2005; 54(RR-5):1-11.
23. Ndiaye SM, Hopkins DP, Shefer AM, Hinman AR, Briss PA, Rodewald L, et al. Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults a systematic review. Am J Prev Med 2005; 28(5 Suppl): 248-79.